Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases

By Jie Zheng, Valeriia Haberland, Denis Baird, V. Walker, Philip C. Haycock, Alex Gutteridge, T. Richardson, James R. Staley, B. Elsworth, Stephen Burgess and 19 more. bioRxiv, 2019

633 citations recorded by the source corpus.

The human proteome is a major source of therapeutic targets. Recent genetic association analyses of the plasma proteome enable systematic evaluation of the causal consequences of variation in plasma protein levels. Here we estimated the effects of 1,002 proteins on 225 phenotypes using two-sample Mendelian randomization (MR) and colocalization. Of 413 associations supported by evidence from MR, 130 (31.5%) were not supported by results of colocalization analyses, suggesting that genetic confounding due to linkage disequilibrium is widespread in naïve phenome-wide association studies of proteins. Combining MR and colocalization evidence in cis -only analyses, we identified 111 putatively causal effects between 65 proteins and 52 disease-related phenotypes ( https://www.epigraphdb.org/pqtl/ ). Evaluation of data from historic drug development programs showed that target-indication pairs with MR and colocalization support were more likely to be approved, evidencing the value of this approach in identifying and prioritizing potential therapeutic targets. Mendelian randomization (MR) and colocalization analyses are used to estimate causal effects of 1,002 plasma proteins on 225 phenotypes. Evidence from drug developmental programs shows that target-indication pairs with MR and colocalization support were more likely to be approved, highlighting the value of this approach for prioritizing therapeutic targets.

Subfields: Genetics, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/c01632bd8027b2bec2145db64389decbc10e557b

Citations in the corpus